Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2026-03-09 @ 8:18 AM
Study NCT ID:
NCT03480802
Status:
COMPLETED
Last Update Posted:
2022-05-05
First Post:
2018-03-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-06
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-17
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-22
First Submit QC Date:
None
Study First Post Date:
2018-03-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-11-02
Results First Submit QC Date:
None
Results First Post Date:
2020-11-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-13
Last Update Post Date:
2022-05-05
Last Update Post Date Type:
ACTUAL